Bio-Rad Laboratories, Inc. v. 10X Genomics Inc. (Fed. Cir. Aug. 3, 2020)
The Court of Appeals for the Federal Circuit vacated the district court's judgment that 10X Genomics infringed the patents of Bio-Rad Laboratories and remanded for a new trial on this issue. A key point relating to infringement was whether or not the preamble of Bio-Rad's two patents (8,304,193 patent and 8,329,407) are limiting. 10X argued that, under the correct claim construction, the preambles limit the claims to methods of conducting reactions inside a microfluidic syste